Tags

Type your tag names separated by a space and hit enter

Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.
J Pediatr. 2009 Dec; 155(6 Suppl):S73-93.JPed

Abstract

Newborn screening for cystic fibrosis (CF) offers the opportunity for early medical and nutritional intervention that can lead to improved outcomes. Management of the asymptomatic infant diagnosed with CF through newborn screening, prenatal diagnosis, or sibling screening is different from treatment of the symptomatically diagnosed individual. The focus of management is on maintaining health by preventing nutritional and respiratory complications. The CF Foundation convened a committee to develop recommendations based on a systematic review of the evidence and expert opinion. These guidelines encompass monitoring and treatment recommendations for infants diagnosed with CF and are intended to help guide families, primary care providers, and specialty care centers in the care of infants with CF.

Authors+Show Affiliations

Women and Children's Hospital of Buffalo, State University of New York at Buffalo, NY, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

19914445

Citation

Cystic Fibrosis Foundation, et al. "Cystic Fibrosis Foundation Evidence-based Guidelines for Management of Infants With Cystic Fibrosis." The Journal of Pediatrics, vol. 155, no. 6 Suppl, 2009, pp. S73-93.
Cystic Fibrosis Foundation, Borowitz D, Robinson KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155(6 Suppl):S73-93.
Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., Marshall, B. C., & Accurso, F. J. (2009). Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of Pediatrics, 155(6 Suppl), S73-93. https://doi.org/10.1016/j.jpeds.2009.09.001
Cystic Fibrosis Foundation, et al. Cystic Fibrosis Foundation Evidence-based Guidelines for Management of Infants With Cystic Fibrosis. J Pediatr. 2009;155(6 Suppl):S73-93. PubMed PMID: 19914445.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. AU - ,, AU - Borowitz,Drucy, AU - Robinson,Karen A, AU - Rosenfeld,Margaret, AU - Davis,Stephanie D, AU - Sabadosa,Kathryn A, AU - Spear,Stephanie L, AU - Michel,Suzanne H, AU - Parad,Richard B, AU - White,Terry B, AU - Farrell,Philip M, AU - Marshall,Bruce C, AU - Accurso,Frank J, PY - 2009/11/17/entrez PY - 2010/2/6/pubmed PY - 2010/2/26/medline SP - S73 EP - 93 JF - The Journal of pediatrics JO - J Pediatr VL - 155 IS - 6 Suppl N2 - Newborn screening for cystic fibrosis (CF) offers the opportunity for early medical and nutritional intervention that can lead to improved outcomes. Management of the asymptomatic infant diagnosed with CF through newborn screening, prenatal diagnosis, or sibling screening is different from treatment of the symptomatically diagnosed individual. The focus of management is on maintaining health by preventing nutritional and respiratory complications. The CF Foundation convened a committee to develop recommendations based on a systematic review of the evidence and expert opinion. These guidelines encompass monitoring and treatment recommendations for infants diagnosed with CF and are intended to help guide families, primary care providers, and specialty care centers in the care of infants with CF. SN - 1097-6833 UR - https://www.unboundmedicine.com/medline/citation/19914445/full_citation DB - PRIME DP - Unbound Medicine ER -